Identification of a gemcitabine-warfarin interaction

Area of Science:

• Oncology
• Pharmacology
• Internal Medicine

Background:

• Warfarin is a common anticoagulant used to prevent blood clots.
• Gemcitabine is a chemotherapy drug used to treat various cancers, including non-small cell lung cancer.
• Managing anticoagulation during chemotherapy requires careful consideration of potential drug interactions.

Observation:

• A patient receiving weekly gemcitabine experienced a significant increase in his international normalized ratio (INR) while on a stable warfarin dose.
• Warfarin dosage adjustments were necessary to maintain a therapeutic INR during gemcitabine treatment.
• INR levels normalized after gemcitabine was discontinued, suggesting a drug interaction.

Findings:

• An interaction between warfarin and gemcitabine was observed, leading to elevated INR levels.
• The interaction occurred shortly after the initiation of gemcitabine therapy.
• Warfarin dosage requirements decreased during gemcitabine treatment and returned to baseline after discontinuation.

Implications:

• Healthcare providers should be aware of the potential interaction between warfarin and gemcitabine.
• Frequent INR monitoring is recommended for patients receiving both medications.
• This interaction may necessitate dose adjustments for warfarin to ensure patient safety and therapeutic efficacy.